Updated:
Agent Capital
Agent Capital is a Waltham-based private equity firm focused on venture and growth investments.
Agent Capital
Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. We make direct equity investments across all stages of development and types of financing rounds.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Waltham
Corporate office
Waltham, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Agent Capital?
No named principals or investment committee members are identified in public sources.
Does Agent Capital participate in fund commitments or only direct deals?
Source material lists venture, growth, and PIPE activity but does not specify fund commitments versus direct deals.
What investment stages does Agent Capital typically target?
The firm lists early-stage seed, start-up, expansion, growth, and pre-IPO stages.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: